215 related articles for article (PubMed ID: 23041672)
1. Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation.
Gong Y; Wang D; Dar JA; Singh P; Graham L; Liu W; Ai J; Xin Z; Guo Y; Wang Z
Endocrinology; 2012 Dec; 153(12):5716-25. PubMed ID: 23041672
[TBL] [Abstract][Full Text] [Related]
2. [Nuclear export signal of androgen receptor regulated of androgen receptor stability in prostate cancer].
Gong YQ; Zhang CJ; He SM; Li XS; Zhou LQ; Guo YL
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):569-574. PubMed ID: 28816267
[TBL] [Abstract][Full Text] [Related]
3. Splicing Factor Prp8 Interacts With NES(AR) and Regulates Androgen Receptor in Prostate Cancer Cells.
Wang D; Nguyen MM; Masoodi KZ; Singh P; Jing Y; O'Malley K; Dar JA; Dhir R; Wang Z
Mol Endocrinol; 2015 Dec; 29(12):1731-42. PubMed ID: 26371515
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
Steely AM; Willoughby JA; Sundar SN; Aivaliotis VI; Firestone GL
Anticancer Drugs; 2017 Oct; 28(9):1018-1031. PubMed ID: 28708672
[TBL] [Abstract][Full Text] [Related]
5. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells.
Lin HK; Altuwaijri S; Lin WJ; Kan PY; Collins LL; Chang C
J Biol Chem; 2002 Sep; 277(39):36570-6. PubMed ID: 12119296
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor.
Saporita AJ; Zhang Q; Navai N; Dincer Z; Hahn J; Cai X; Wang Z
J Biol Chem; 2003 Oct; 278(43):41998-2005. PubMed ID: 12923188
[TBL] [Abstract][Full Text] [Related]
7. A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.
Amin KS; Jagadeesh S; Baishya G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer Ther; 2014 Feb; 13(2):341-52. PubMed ID: 24258347
[TBL] [Abstract][Full Text] [Related]
8. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
[TBL] [Abstract][Full Text] [Related]
9. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.
Liao Y; Liu N; Hua X; Cai J; Xia X; Wang X; Huang H; Liu J
Cell Death Dis; 2017 Feb; 8(2):e2585. PubMed ID: 28151478
[TBL] [Abstract][Full Text] [Related]
10. The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells.
Fan L; Peng G; Hussain A; Fazli L; Guns E; Gleave M; Qi J
J Biol Chem; 2015 Aug; 290(34):20865-20879. PubMed ID: 26160177
[TBL] [Abstract][Full Text] [Related]
11. Enzalutamide-induced Proteolytic Degradation of the Androgen Receptor in Prostate Cancer Cells Is Mediated Only to a Limited Extent by the Proteasome System.
Erb HHH; Oster MA; Gelbrich N; Cammann C; Thomas C; Mustea A; Stope MB
Anticancer Res; 2021 Jul; 41(7):3271-3279. PubMed ID: 34230121
[TBL] [Abstract][Full Text] [Related]
12. DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.
Jing Y; Nguyen MM; Wang D; Pascal LE; Guo W; Xu Y; Ai J; Deng FM; Masoodi KZ; Yu X; Zhang J; Nelson JB; Xia S; Wang Z
Oncogene; 2018 Feb; 37(5):638-650. PubMed ID: 28991234
[TBL] [Abstract][Full Text] [Related]
13. Degradation and beyond: control of androgen receptor activity by the proteasome system.
Jaworski T
Cell Mol Biol Lett; 2006; 11(1):109-31. PubMed ID: 16847754
[TBL] [Abstract][Full Text] [Related]
14. Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells.
Varisli L; Gonen-Korkmaz C; Syed HM; Bogurcu N; Debelec-Butuner B; Erbaykent-Tepedelen B; Korkmaz KS
Mol Cell Endocrinol; 2012 Mar; 350(1):107-17. PubMed ID: 22155408
[TBL] [Abstract][Full Text] [Related]
15. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells.
Dar JA; Masoodi KZ; Eisermann K; Isharwal S; Ai J; Pascal LE; Nelson JB; Wang Z
J Steroid Biochem Mol Biol; 2014 Sep; 143():473-80. PubMed ID: 24662325
[TBL] [Abstract][Full Text] [Related]
17. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.
Schütz SV; Cronauer MV; Rinnab L
J Cell Biochem; 2010 Apr; 109(6):1192-200. PubMed ID: 20127713
[TBL] [Abstract][Full Text] [Related]
19. Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.
Mizutani N; Inoue M; Omori Y; Ito H; Tamiya-Koizumi K; Takagi A; Kojima T; Nakamura M; Iwaki S; Nakatochi M; Suzuki M; Nozawa Y; Murate T
J Biochem; 2015 Oct; 158(4):309-19. PubMed ID: 25888580
[TBL] [Abstract][Full Text] [Related]
20. Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer.
Lv S; Song Q; Chen G; Cheng E; Chen W; Cole R; Wu Z; Pascal LE; Wang K; Wipf P; Nelson JB; Wei Q; Huang W; Wang Z
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33332287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
